MK-677 (Ibutamoren) and Acetaminophen Interaction: What You Need to Know
A guide to the MK-677 (ibutamoren) and acetaminophen drug interaction, covering hepatic toxicity overlap, CYP enzyme effects, monitoring, dosing, and patient counseling.
Mk 677: Drug Interactions
30 source-based articles maintained by the HealthRX.com Editorial Team.
30articles
3topic areas covered
Jul 10, 2025latest review
Mk 677: Drug Interactions library
Showing 30 of 30 clinical reviews.
MK-677 (Ibutamoren) and Apixaban Interaction: What Clinicians and Patients Need to Know
A clinical review of the MK-677 (ibutamoren) and apixaban drug interaction, covering CYP3A4 and P-glycoprotein pathways, pharmacodynamic risks, monitoring parameters, and dose-adjustment guidance.
MK-677 (Ibutamoren) and Atorvastatin Interaction: What You Need to Know
A guide to the MK-677 (ibutamoren) and atorvastatin drug interaction, covering CYP3A4 mechanism, glucose effects, myopathy risk, monitoring parameters, and clinical dosing guidance.
MK-677 (Ibutamoren) and Benzodiazepines Interaction: What Clinicians and Patients Need to Know
An evidence-based analysis of the pharmacokinetic and pharmacodynamic interactions between MK-677 (ibutamoren) and benzodiazepines, including CNS depression risk, CYP3A4 overlap, GH/IGF-1 effects on sedation, monitoring protocols, and patient counseling guidance.
MK-677 (Ibutamoren) and Bupropion Interaction: What Clinicians and Patients Need to Know
A clinical review of the MK-677 (ibutamoren) and bupropion drug interaction, covering CYP2D6 metabolism, seizure-threshold concerns, blood glucose effects, and monitoring recommendations.
MK-677 (Ibutamoren) and Clopidogrel Interaction: CYP2C19 Risk, Monitoring, and Clinical Guidance
Can you take MK-677 (ibutamoren) with clopidogrel? This guide covers the CYP2C19-mediated interaction, antiplatelet efficacy concerns, monitoring parameters, and dose-adjustment strategies.
MK-677 (Ibutamoren) and Diphenhydramine Interaction: Risks, Mechanisms, and Clinical Guidance
A cautious, mechanism-based review of combining MK-677 (ibutamoren) with diphenhydramine, covering sedation overlap, anticholinergic burden, metabolic effects, and what remains unverified.
MK-677 (Ibutamoren) and Estradiol HRT Interaction: What Clinicians and Patients Need to Know
A detailed clinical review of the pharmacodynamic and pharmacokinetic interactions between MK-677 (ibutamoren) and estradiol HRT, covering VTE risk, IGF-1 amplification, monitoring protocols, and patient counseling guidance.
MK-677 (Ibutamoren) and Finasteride Interaction: Safety, Risks, and Clinical Guidance
Can you take MK-677 (ibutamoren) with finasteride? Review the pharmacokinetic and pharmacodynamic interaction profile, monitoring protocols, and dose-adjustment guidance for this combination.
MK-677 (Ibutamoren) and Gabapentin Interaction: What You Need to Know
A clinical deep-dive into the pharmacodynamic and pharmacokinetic interaction between MK-677 (ibutamoren) and gabapentin, covering sedation risk, renal overlap, monitoring parameters, and patient counseling for anyone combining these compounds.
MK-677 (Ibutamoren) and Hormonal Contraceptives: Interaction Guide
A analysis of the pharmacokinetic and pharmacodynamic interactions between MK-677 (ibutamoren) and hormonal contraceptives, including CYP3A4 overlap, IGF-1 effects on SHBG, monitoring guidance, and patient counseling.
MK-677 (Ibutamoren) and Levothyroxine Interaction: Safety, Risks, and Monitoring
Can you take MK-677 (ibutamoren) with levothyroxine? What is established about the GH-thyroid axis interaction, what is plausible but unproven, and what a clinician should verify before adjusting a thyroid regimen.
MK-677 (Ibutamoren) and Metformin Interaction: What Clinicians and Patients Should Know
A clinical review of the pharmacodynamic interaction between MK-677 (ibutamoren) and metformin, covering glucose metabolism effects, monitoring protocols, and evidence-based risk assessment.
MK-677 (Ibutamoren) and NSAIDs (Ibuprofen, Naproxen): Interaction Risks, Mechanisms, and Clinical Guidance
A analysis of the MK-677 (ibutamoren) and NSAID interaction, covering GI, renal, and metabolic overlap risks with monitoring and dose-adjustment guidance.
MK-677 (Ibutamoren) and Opioids Interaction: Risks, Mechanisms, and Clinical Guidance
Clinical analysis of the MK-677 (ibutamoren) and opioid (oxycodone, hydrocodone, tramadol) interaction including CNS depression risk, CYP3A4 overlap, monitoring parameters, and dose-adjustment strategies.
MK-677 (Ibutamoren) and PPIs (Omeprazole, Pantoprazole): Interaction Guide
Can you take MK-677 (ibutamoren) with a PPI like omeprazole or pantoprazole? A cautious review of the pharmacokinetic overlap, CYP3A4 considerations, glucose monitoring, and what remains unverified for this combination.
MK-677 (Ibutamoren) and Prednisone Interaction: Risks, Monitoring, and Clinical Guidance
A analysis of the pharmacodynamic interaction between MK-677 (ibutamoren) and prednisone, covering glucose dysregulation, bone density concerns, immunosuppression overlap, and monitoring protocols.
MK-677 (Ibutamoren) and Pregabalin Interaction: Risks, Mechanisms, and Clinical Guidance
Can you take MK-677 (ibutamoren) with pregabalin? Learn about the pharmacodynamic overlap, sedation risk, metabolic effects, monitoring requirements, and dose-adjustment strategies for this combination.
MK-677 (Ibutamoren) and Progesterone HRT Interaction: What You Need to Know
A guide to the pharmacokinetic and pharmacodynamic interactions between MK-677 (ibutamoren) and progesterone HRT, including sedation risk, CYP3A4 pathways, monitoring, and dose guidance.
MK-677 (Ibutamoren) and Rivaroxaban Interaction: What Clinicians and Patients Should Know
A clinical review of the MK-677 (ibutamoren) and rivaroxaban drug interaction, covering CYP3A4 and P-glycoprotein overlap, bleeding risk, GH-mediated coagulation changes, monitoring parameters, and dose-adjustment guidance.
MK-677 (Ibutamoren) and Rosuvastatin Interaction: What You Need to Know
A guide to the pharmacokinetic and pharmacodynamic interaction between MK-677 (ibutamoren) and rosuvastatin, including mechanism, severity, monitoring, and patient counseling.
MK-677 (Ibutamoren) and Sildenafil Interaction: What Clinicians and Patients Need to Know
A deep dive into the pharmacokinetic and pharmacodynamic interaction between MK-677 (ibutamoren) and sildenafil, covering CYP3A4, blood pressure risks, monitoring protocols, and dosing guidance.
MK-677 (Ibutamoren) and Simvastatin Interaction: What Patients and Clinicians Need to Know
A clinical deep-dive into the pharmacokinetic and pharmacodynamic interaction between MK-677 (ibutamoren) and simvastatin, including CYP3A4 mechanisms, rhabdomyolysis risk, monitoring parameters, and dose-adjustment guidance.
MK-677 (Ibutamoren) and SNRIs (Venlafaxine, Duloxetine): Interaction Risk, Mechanism, and Monitoring
Clinical analysis of the MK-677 and SNRI drug interaction, covering pharmacokinetic overlap, blood pressure effects, serotonin-adjacent risks, CYP3A4 metabolism, and monitoring protocols.
MK-677 (Ibutamoren) and SSRIs (Sertraline, Escitalopram): Interaction Risk, Safety, and Monitoring
Can you take MK-677 (ibutamoren) with SSRIs like sertraline or escitalopram? Review the pharmacokinetic and pharmacodynamic interaction profile, serotonin syndrome risk, blood sugar effects, and clinical monitoring recommendations.
MK-677 (Ibutamoren) and Tadalafil Interaction: Safety, Mechanisms, and Clinical Guidance
A clinical review of the MK-677 (ibutamoren) and tadalafil drug interaction, covering CYP3A4 metabolism overlap, pharmacodynamic risks, blood pressure effects, and monitoring recommendations.
MK-677 (Ibutamoren) and Testosterone Interaction
Clinical review of the MK-677 (ibutamoren) and testosterone interaction, covering pharmacodynamic overlap, safety monitoring, polycythemia risk, lipid effects, and evidence-based dosing guidance.
MK-677 (Ibutamoren) and Trazodone Interaction: Safety, Risks, and Clinical Guidance
Can you take MK-677 (ibutamoren) with trazodone? Review the pharmacokinetic and pharmacodynamic interaction profile, sedation overlap, CYP3A4 considerations, monitoring parameters, and dose-adjustment guidance.
MK-677 (Ibutamoren) and Warfarin Interaction: What Patients and Clinicians Need to Know
A analysis of the MK-677 (ibutamoren) and warfarin interaction, covering mechanisms, INR monitoring, dose-adjustment guidance, and patient counseling.
MK-677 (Ibutamoren) and Zolpidem Interaction: What Patients and Clinicians Need to Know
A analysis of the MK-677 (ibutamoren) and zolpidem drug interaction, covering pharmacokinetic mechanisms, CNS depression risk, CYP3A4 overlap, monitoring parameters, and safe-use guidance.